Guía de consenso sobre la gonadectomía profiláctica en el desarrollo sexual diferente

Lee, 2006, Consensus statement on management of intersex disorders, Pediatrics, 118, e488, 10.1542/peds.2006-0738 Slowikowska-Hilczer, 2020, Risk of gonadal neoplasia in patients with disorders/differences of sex development, Cancer Epidemiol., 69, 101800, 10.1016/j.canep.2020.101800 Lucas-Herald, 2021, Gonadectomy in conditions affecting sex development - A Registry-Based Cohort Study, Eur J Endocrinol., 184, 791, 10.1530/EJE-20-1058 Hersmus, 2008, New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD), Mol Cell Endocrinol., 291, 1, 10.1016/j.mce.2008.02.028 Pyle, 2017, A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development, Am J Med Genet C Semin Med Genet., 175, 304, 10.1002/ajmg.c.31562 Ulbright, 2014, Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development, Semin Diagn Pathol., 31, 427, 10.1053/j.semdp.2014.07.001 Van der Zwan, 2015, Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model, Eur Urol., 67, 692, 10.1016/j.eururo.2014.07.011 Cools, 2014, Managing the risk of germ cell tumourigenesis in disorders of sex development patients. understanding differences and disorders of sex development (DSD), Endocr Dev., 27, 185, 10.1159/000363642 Hersmus, 2017, The biology of germ cell tumors in disorders of sex development, Clin Genet., 91, 292, 10.1111/cge.12882 Spoor, 2018, Histological assessment of gonads in DSD: relevance for clinical management, Sex Dev., 12, 106, 10.1159/000481757 Scully, 1970, Gonadoblastoma. A review of 74 cases, Cancer., 25, 1340, 10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N Cools, 2009, Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors, World J Pediatr., 5, 93, 10.1007/s12519-009-0020-7 Cools, 2011, Gonadal development and tumor formation at the crossroads of male and female sex determination, Sex Dev., 5, 167, 10.1159/000329477 Huang, 2017, Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence, Clin Endocrinol., 86, 621, 10.1111/cen.13255 Nistal, 2015, Perspectives in pediatric pathology, Chapter 5 Gonadal dysgenesis, Pediatr Dev Pathol., 18, 259, 10.2350/14-04-1471-PB.1 Cools, 2006, Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers, Endocr Rev., 27, 468, 10.1210/er.2006-0005 Cools, 2005, Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes, J Clin Endocrinol Metab., 90, 5295, 10.1210/jc.2005-0139 Ulbright, 2014, Am J Surg Pathol., 38, e50, 10.1097/PAS.0000000000000233 Wolffenbuttel, 2016, Gonadal dysgenesis in disorders of sex development: Diagnosis and surgical management, J Pediatr Urol., 12, 411, 10.1016/j.jpurol.2016.08.015 Looijenga, 2019, Predicting gonadal germ cell cancer in people with disorders of sex development; insights from developmental biology, Int J Mol Sci., 20, 5017, 10.3390/ijms20205017 Pleskacova, 2010, Tumor risk in disorders of sex development, Sex Dev., 4, 259, 10.1159/000314536 Nistal, 2017, Disorders of sexual development from the pathologist's perspective, 9 Looijenga, 2007, Tumor risk in disorders of sex development (DSD), Best Pract Res Clin Endocrinol Metab., 21, 480, 10.1016/j.beem.2007.05.001 Moch, 2016, The 2016 WHO Classification of tumours of the urinary system and male genital organs-Part A: Renal penile, and testicular tumours, Eur Urol., 70, 93, 10.1016/j.eururo.2016.02.029 Emerson, 2020, 13 - Neoplasms of the Testis, 731 Cools, 2018, Caring for individuals with a difference of sex development (DSD): a Consensus Statement, Nat Rev Endocrinol., 14, 415, 10.1038/s41574-018-0010-8 Callens, 2016, Recalled and current gender role behavior, gender identity and sexual orientation in adults with Disorders/Differences of Sex Development, Horm Behav., 86, 8, 10.1016/j.yhbeh.2016.08.008 Finlayson, 2017, Presence of germ cells in disorders of sex development: implications for fertility potential and preservation, J Urol., 197, 937, 10.1016/j.juro.2016.08.108 Islam, 2019, Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development, Clin Endocrinol (Oxf)., 91, 237, 10.1111/cen.13994 Weidler, 2019, Clinical management in mixed gonadal dysgenesis with chromosomal mosaicism: Considerations in newborns and adolescents, Semin Pediatr Surg., 28, 150841, 10.1016/j.sempedsurg.2019.150841 Cools, 2011, Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46 XY mosaicism, J Clin Endocrinol Metab., 96, E1171, 10.1210/jc.2011-0232 Grinspon, 2016, Disorders of sex development with testicular differentiation in SRY-Negative 46XX individuals: clinical and genetic aspects, Sex Dev., 10, 1, 10.1159/000445088 Şimşek, 2016, Gonadoblastoma and papillary tubal hyperplasia in ovotesticular disorder of sexual development, J Clin Res Pediatr Endocrinol., 8, 351, 10.4274/jcrpe.2705 Li, 2020, 46 XX Ovotesticular disorder of sex development (true hermaphroditism) with seminoma: A case report, Medicine (Baltimore)., 99, e22530, 10.1097/MD.0000000000022530 Delforge, 2020, A novel approach in the intraoperative management of ovotesticular DSD, J Pediatr Urol., 16, 768, 10.1016/j.jpurol.2020.10.007 Shankar, 2014, Oophorectomy versus salpingo-oophorectomy in Turner syndrome patients with Y-chromosome material: clinical experience and current practice patterns assessment, J Pediatr Surg., 49, 1585, 10.1016/j.jpedsurg.2014.06.012 Zelaya, 2015, Gonadoblastoma in patients with Ullrich-Turner syndrome, Pediatr Dev Pathol., 18, 117, 10.2350/14-08-1539-OA.1 Kwon, 2017, Risk of gonadoblastoma development in patients with Turner syndrome with cryptic Y chromosome material, Horm Cancer., 8, 166, 10.1007/s12672-017-0291-8 Silveri, 2016, Ullrich-Turner syndrome and tumor risk: is there another chance to early gonadectomy in positive TSPY and SRY patients?, Eur J Pediatr Surg., 26, 273 Barros, 2011, OCT4 immunohistochemistry may be necessary to identify the real risk of gonadal tumors in patients with Turner syndrome and Y chromosome sequences, Hum Reprod., 26, 3450, 10.1093/humrep/der310 Oliveira, 2009, Y chromosome in Turner syndrome: review of the literature, Sao Paulo Med J., 127, 373, 10.1590/S1516-31802009000600010 Brooke, 2006, A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency, J Clin Endocrinol Metab., 91, 2428, 10.1210/jc.2005-2653 Deeb, 2015, 17-hydroxylase/17,20-lyase deficiency due to a R96Q mutation causing hypertension and poor breast development, Endocrinol Diabetes Metab Case Rep., 2015, 150069 Kersemaekers, 2005, Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY, Hum Pathol., 36, 512, 10.1016/j.humpath.2005.02.016 Werner, 2015, 46 XY gonadal dysgenesis due to a homozygous mutation in desert hedgehog (DHH) Identified by exome sequencing, J Clin Endocrinol Metab., 100, E1022, 10.1210/jc.2015-1314 Fredette, 2019, Early-onset gonadoblastoma in a 13-month-old infant with 46,XY complete gonadal dysgenesis identified with prenatal testing: a case of chromosome 9p deletion, AACE Clin Case Rep., 5, e380, 10.4158/ACCR-2019-0285 Tang, 2019, Novel mutation in FTHL17 gene in pedigree with 46XY pure gonadal dysgenesis, Fertil Steril., 111, 1226, 10.1016/j.fertnstert.2019.01.027 Bhagavath, 2014, Familial 46 XY sex reversal without campomelic dysplasia caused by a deletion upstream of the SOX9 gene, Mol Cell Endocrinol., 393, 1, 10.1016/j.mce.2014.05.006 White, 2012, A multi-exon deletion within WWOX is associated with a 46XY disorder of sex development, Eur J Hum Genet., 20, 348, 10.1038/ejhg.2011.204 Cools, 2012, Pubertal androgenization and gonadal histology in two 46 XY adolescents with NR5A1 mutations and predominantly female phenotype at birth, Eur J Endocrinol., 166, 341, 10.1530/EJE-11-0392 Sasaki, 2003, Giant seminoma in a patient with 5 alpha-reductase type 2 deficiency, J Urol., 169, 1080, 10.1097/01.ju.0000047621.66463.29 Abacı, 2019, Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey, J Endocrinol Invest., 42, 453, 10.1007/s40618-018-0940-y Manuel, 1976, The age of occurrence of gonadal tumors in intersex patients with a Y chromosome, Am J Obstet Gynecol., 124, 293, 10.1016/0002-9378(76)90160-5 Cools, 2017, Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling, Hum Reprod., 32, 2561, 10.1093/humrep/dex300 Patel, 2016, Timing of gonadectomy in patients with complete androgen insensitivity syndrome-current recommendations and future directions, J Pediatr Adolesc Gynecol., 29, 320, 10.1016/j.jpag.2015.03.011 Tack, 2018, Management of gonads in adults with androgen insensitivity: an international survey, Horm Res Paediatr., 90, 236, 10.1159/000493645 Nakhal, 2013, Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndrome, Radiology., 268, 153, 10.1148/radiol.13121068 Muttarak, 2004, Malignant germ cell tumours of undescended testes: imaging features with pathological correlation, Clin Radiol., 59, 198, 10.1016/j.crad.2003.07.008 Wünsch, 2012, Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis, BJU Int., 110, E958, 10.1111/j.1464-410X.2012.11181.x